نتایج جستجو برای: 131i mibg scintigraphy

تعداد نتایج: 11771  

Journal: :The Journal of clinical endocrinology and metabolism 2009
Henri J L M Timmers Clara C Chen Jorge A Carrasquillo Millie Whatley Alexander Ling Bastiaan Havekes Graeme Eisenhofer Lucia Martiniova Karen T Adams Karel Pacak

CONTEXT Besides (123)I-metaiodobenzylguanidine (MIBG), positron emission tomography (PET) agents are available for the localization of paraganglioma (PGL), including (18)F-3,4-dihydroxyphenylalanine (DOPA), (18)F-fluoro-2-deoxy-D-glucose ((18)F-FDG), and (18)F-fluorodopamine ((18)F-FDA). OBJECTIVE The objective of the study was to establish the optimal approach to the functional imaging of PG...

2009
Masaru Tateno Seiju Kobayashi Toshikazu Saito

Dementia with Lewy bodies (DLB) is the second most common cause of degenerative dementia after Alzheimer's disease (AD), and is clinically characterized by the progressive cognitive decline with fluctuations in cognition and alertness, recurrent visual hallucinations and Parkinsonism. Once these characteristic symptoms of DLB emerge, discriminating it from AD is relatively easy. However, in the...

Objective: The current study aimed to determine the efficacy of radioiodine-131 (131I) ablation therapy with thyroid hormone replacement one day before 131I administration in patients with well-differentiated thyroid cancer (DTC). Methods: This retrospective study included 29 patients who underwent 131I therapies twice for DTC during 6-12 months.  Since all the patients obviously had residual l...

Journal: :Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2007
Takaya Tsuchida Nagaharu Fukuma Keiko Oikawa Kazuyo Kato Yuko Kato Teruo Takano Shinichiro Kumita

BACKGROUND Past studies suggested that plasma norepinephrine during exercise originates in sympathetic nerve endings and that the main origin differs among pathophysiological conditions. AIMS This study investigated the most important site of sympathetic terminals as an origin of plasma norepinephrine during exercise in patients with heart failure using (123)I- metaiodobenzylguanidine (MIBG) ...

Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used to evaluate cardiac sympathetic denervation in Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). The heart-tomediastinum ratio (H/M) in PD and DLB is significantly lower than that in Parkinson’s plus syndromes and Alzheimer’s disease. Although this ra...

2012
Beata E. Chrapko Andrzej Tomaszewski Andrzej J. Jaroszyński Jacek Furmaga Andrzej Wysokiński Sławomir Rudzki

BACKGROUND Takotsubo syndrome (TTS) is a transient cardiomyopathy of unknown origin, clinically manifesting as acute coronary syndrome (ACS). This syndrome mainly occurs in postmenopausal women and has a temporary relationship with emotional or physical stress. CASE REPORT TTS occurred in 46-year-old female patient on the first day after renal transplantation. The predominant symptoms were co...

Journal: :QJM : monthly journal of the Association of Physicians 1996
J K Ramage R Williams M Buxton-Thomas

Functional imaging of neuroendocrine tumours with Octreoscan and I123-metaiodobenzylguanidine (MIBG) is important for assessment prior to various therapies and assessing response. The two imaging methods have not been directly compared in hepatic neuroendocrine tumours. Patients (n = 18) were studied with both imaging techniques. The sensitivity of Octreoscan was 94%, and that of MIBG 39%. No p...

2015
Yasuki Maruyama Takayuki Yamada Kenji Murakami Reiko Kumano

OBJECTIVES The aim of the study was to compare the diagnostic performance of early-phase I-metaiodobenzylguanidine (MIBG) scintigraphy with that of delayed-phase imaging in Lewy body disease (LBD). METHODS A retrospective cohort study of ¹²³I-MIBG scintigraphy was carried out in 192 patients who were suspected of having LBD. Clinical diagnosis was obtained using the UK Parkinson's Disease Bra...

Journal: :asia oceania journal of nuclear medicine and biology 0
daiki kayano daiki kayano: department of nuclear medicine, kanazawa university hospital junichi taki department of nuclear medicine, kanazawa university hospital anri inaki department of nuclear medicine, kanazawa university hospital hiroshi wakabayashi department of nuclear medicine, kanazawa university hospital ayane nakamura department of nuclear medicine, kanazawa university hospital makoto fukuoka department of nuclear medicine, kanazawa university hospital

objective: the current study aimed to determine the efficacy of radioiodine-131 (131i) ablation therapy with thyroid hormone replacement one day before 131i administration in patients with well-differentiated thyroid cancer (dtc). methods: this retrospective study included 29 patients who underwent 131i therapies twice for dtc during 6-12 months.  since all the patients obviously had residual l...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید